TELA Bio, Inc. Deferred Costs, Noncurrent
TELA Bio, Inc. (TELA) had Deferred Costs, Noncurrent of $1.73 million as of 2019-09-30, per its 10-Q filed 2019-12-18.
Discontinued › Balance Sheet › Assets
us-gaap:DeferredCosts · last filed 2019-12-18
- 2019-09-30: Deferred Costs, Noncurrent $1.73M.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2019-09-30 | $1.73M 10-Q · filed 2019-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |